Healthcare & Medical Devices Global On demand · 24-48h

Global Ultrasonically Activated Scalpel (UAS) Market Strategic Research Report

Global Ultrasonically Activated Scalpel (UAS) Market Strateg…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Ultrasonically Activated Scalpel (UAS) Market
$3.86B2025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Monopolar (Monopolar Cutting/Monopolar Coagulation), Bipolar (Bipolar Cutting/Bipolar Coagulation)

By Application: Hospital, Outpatient Surgery Center, Scientific Research Laboratory, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Integra LifeSciences, Johnson&Johnson(Ethicon Inc.), Medtronic, Olympus America, Stryker Corporation, Söring GmbH, BOWA MEDICAL, Bioventus(MISONIX, Inc.), Genesis MedTech(Reach Surgical), Apollo Technosystems, Ethicon Endo-Surgery, VDW GmbH, Advanced Instrumentations, MISONIX, Inc., B. Braun Holding GmbH&Co.KG, CONMED, Heritage Electromedicine GmbH, LED SpA, Cooper Medical, Inc., Miconvey, Lepu Medical Technology, Innolcon Medical Technology Co., Ltd., Hocermed (Tianjin) Medical Technology Co., Ltd

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 155 pages
Market size 2025
$3.86B
Billion USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$5.7B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Ultrasonically Activated Scalpel (UAS) market size is predicted to grow from US$ 3,859 million in 2025 to US$ 5,627 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

Ultrasonic energy is an efficient alternative to electrosurgery and the basis for an efficient surgical instrument. The device cuts and coagulates by using lower temperatures than those used by electrosurgery or lasers. No electricity goes to or through the patient.The ultrasonically activated scalpel (UAS) is characterized by its ability to cut and coagulate tissues simultaneously with relatively low heat and limited lateral thermal injury. The UAS has been used routinely in a number of general surgeries, including laparoscopic surgeries and open surgeries of the lung and liver.The basic mechanism for coagulating bleeding vessels by UAS is similar to that of electrosurgery or lasers, in that vessels are sealed and occluded with denatured protein. However, the manner in which protein is denatured is different for each modality. Electrosurgery and lasers denature protein by heating the tissues with electric current in the former and light in the latter at a very high temperature. The UAS denatures protein by transferring mechanical energy to ultrasonic high frequency vibration (25Khz - 55KHz). The vibration breaks hydrogen bonds and produces frictional heat. This frictional heat produces lower maximum temperature and slower increase in tissue temperature than the heat from electrocautery. The cutting mechanism for the UAS is also different from that observed with electrosurgery or laser surgery. UAS cuts tissues by a relatively sharp blade vibrating at 25Khz - 55Khz over a distance of up 100µm.

The market drivers for this product are the increasing prevalence of chronic diseases such as cancer and cardiovascular diseases, the rising demand for minimally invasive surgeries, and the technological advancements in UEUs.

The constraints of this product are the high cost of UEUs, the lack of skilled professionals, and the regulatory and safety issues associated with UEUs.

The future opportunities for this product are the development of new and improved UEUs with enhanced features and performance, the expansion of the market in emerging regions such as Asia-Pacific and Latin America, and the innovation of new applications and segments for UEUs.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ultrasonically Activated Scalpel (UAS) market?

What factors are driving Ultrasonically Activated Scalpel (UAS) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ultrasonically Activated Scalpel (UAS) market opportunities vary by end market size?

How does Ultrasonically Activated Scalpel (UAS) break out by Type, by Application?

This report presents a comprehensive overview of the global Ultrasonically Activated Scalpel (UAS) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Monopolar (Monopolar Cutting/Monopolar Coagulation)
  • Bipolar (Bipolar Cutting/Bipolar Coagulation)

Segment by Application

  • Hospital
  • Outpatient Surgery Center
  • Scientific Research Laboratory
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ultrasonically Activated Scalpel (UAS) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Outpatient Surgery Center, Scientific Research Laboratory evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Ultrasonically Activated Scalpel (UAS) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.86B
2025
Forecast
$5.7B
2032
CAGR
5.6%
2025–2032
Régions
5
global
Key companies
Integra LifeSciencesJohnson&Johnson(Ethicon Inc.)MedtronicOlympus AmericaStryker CorporationSöring GmbHBOWA MEDICALBioventus(MISONIX
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Monopolar (Monopolar Cutting/Monopolar Coagulation)Bipolar (Bipolar Cutting/Bipolar Coagulation)
By Application
HospitalOutpatient Surgery CenterScientific Research LaboratoryOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Monopolar (Monopolar Cutting/Monopolar Coagulation)
  • 3.1.3 Bipolar (Bipolar Cutting/Bipolar Coagulation)
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Outpatient Surgery Center
  • 4.1.4 Scientific Research Laboratory
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Integra LifeSciences
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Johnson&Johnson(Ethicon Inc.)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Medtronic
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Olympus America
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Stryker Corporation
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Söring GmbH
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BOWA MEDICAL
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Bioventus(MISONIX,Inc.)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Genesis MedTech(Reach Surgical)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Apollo Technosystems
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Ethicon Endo-Surgery
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 VDW GmbH
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Advanced Instrumentations
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 MISONIX,Inc.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 B. Braun Holding GmbH&Co.KG
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 CONMED
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Heritage Electromedicine GmbH
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 LED SpA
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Cooper Medical,Inc.
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Miconvey
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Lepu Medical Technology
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Innolcon Medical Technology Co.,Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Hocermed (Tianjin) Medical Technology Co.,Ltd
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Ultrasonically Activated Scalpel (UAS) market size?
The global Ultrasonically Activated Scalpel (UAS) market is estimated at US$ 3.86 billion in 2025 (base year) and is projected to reach US$ 5.63 billion by 2032.
What growth rate is expected for the Ultrasonically Activated Scalpel (UAS) market through 2032?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 3.86 billion in 2025 to US$ 5.63 billion in 2032, roughly 1.5 times its base-year value.
How is Ultrasonically Activated Scalpel (UAS) defined?
Ultrasonic energy is an efficient alternative to electrosurgery and the basis for an efficient surgical instrument. The device cuts and coagulates by using lower temperatures than those used by electrosurgery or lasers. No electricity goes to or through the patient.The ultrasonically activated scalpel (UAS) is characterized by its ability to cut and coagulate tissues simultaneously with relatively low heat and limited lateral thermal injury.
How is the Ultrasonically Activated Scalpel (UAS) market segmented by type?
By type, the market is segmented into Monopolar (Monopolar Cutting/Monopolar Coagulation) and Bipolar (Bipolar Cutting/Bipolar Coagulation).
What are the key applications of Ultrasonically Activated Scalpel (UAS)?
Key applications covered include Hospital, Outpatient Surgery Center, Scientific Research Laboratory and Other.
Which companies are profiled in the Ultrasonically Activated Scalpel (UAS) market report?
Key players profiled include Integra LifeSciences, Johnson&Johnson(Ethicon Inc.), Medtronic, Olympus America, Stryker Corporation, Söring GmbH, BOWA MEDICAL and Bioventus(MISONIX,Inc.), among 23 companies covered in total.
What geographies does the Ultrasonically Activated Scalpel (UAS) market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Ultrasonically Activated Scalpel (UAS)?
What factors are driving Ultrasonically Activated Scalpel (UAS) market growth, globally and by region?
What are the main risks and barriers in the Ultrasonically Activated Scalpel (UAS) market?
The constraints of this product are the high cost of UEUs, the lack of skilled professionals, and the regulatory and safety issues associated with UEUs.
Who should buy the Ultrasonically Activated Scalpel (UAS) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Outpatient Surgery Center and Scientific Research Laboratory, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Ultrasonically Activated Scalpel (UAS) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.